Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.81131 | 34 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.78127 | 34 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.78302 | 34 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.69274 | 33 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.72449 | 34 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.87923 | 35 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.82633 | 34 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.75468 | 34 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.72439 | 33 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.76487 | 34 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.7653 | 34 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.74665 | 34 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.77399 | 34 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.77209 | 34 |